Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Hypoglycemia is one of the severe complications of diabetes. To prevent hypoglycemia, an emphasis is placed on maintaining an appropriate balance between nutrition, activity, and treatment, which can be achieved by the repetition of self-trials based on self-monitoring. Clinicians routinely focus on patients’ contribution, including timely intake of an adequate amount of carbohydrates, physical activity, antidiabetic medication, and abstinence from alcohol. Recently, many guidelines have highlighted the importance of clinicians’ factors and recommend individualized treatments according to lifestyle patterns and specific needs following the de-intensification of treatment. The optimal value of hemoglobin A1c (HbA1c) levels for blood glucose level regulation remains controversial among countries, but it generally does not exceed 8.0%. In populations that are at a risk of hypoglycemia, such as the older adults, it is advisable to adjust the target blood glucose level to less than 8.0%. Meanwhile, a blood glucose level of 7.0%–7.5% is generally recommended for healthy older adults. If the expected lifetime is shorter than 10 years or in patients with chronic kidney disease and severe cardiovascular disease, the HbA1c level target can be increased to 7.5%–8.0%. For even shorter lifetime expectancy, the target can be adjusted up to 8.0%–9.0%. To prevent hypoglycemia, the target blood glucose level needs to be adjusted, particularly in older adult patients. Ultimately, it is important to identify the maximum blood glucose levels that do not cause hypoglycemia and the minimum blood glucose levels that do not cause hyperglycemia-associated complications.
Abstract
Hypoglycemia is one of the severe complications of diabetes. To prevent hypoglycemia, an emphasis is placed on maintaining an appropriate balance between nutrition, activity, and treatment, which can be achieved by the repetition of self-trials based on self-monitoring. Clinicians routinely focus on patients’ contribution, including timely intake of an adequate amount of carbohydrates, physical activity, antidiabetic medication, and abstinence from alcohol. Recently, many guidelines have highlighted the importance of clinicians’ factors and recommend individualized treatments according to lifestyle patterns and specific needs following the de-intensification of treatment. The optimal value of hemoglobin A1c (HbA1c) levels for blood glucose level regulation remains controversial among countries, but it generally does not exceed 8.0%. In populations that are at a risk of hypoglycemia, such as the older adults, it is advisable to adjust the target blood glucose level to less than 8.0%. Meanwhile, a blood glucose level of 7.0%–7.5% is generally recommended for healthy older adults. If the expected lifetime is shorter than 10 years or in patients with chronic kidney disease and severe cardiovascular disease, the HbA1c level target can be increased to 7.5%–8.0%. For even shorter lifetime expectancy, the target can be adjusted up to 8.0%–9.0%. To prevent hypoglycemia, the target blood glucose level needs to be adjusted, particularly in older adult patients. Ultimately, it is important to identify the maximum blood glucose levels that do not cause hypoglycemia and the minimum blood glucose levels that do not cause hyperglycemia-associated complications.
참고문헌 (37)
- 고승현, "Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association", The Korean Journal of Internal Medicine, 32(6), pp.947~958 (2017), 대한내과학회[DOI]
- 고승현, "Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association", Diabetes and Metabolism Journal, 41(5), pp.337~348 (2017), 대한당뇨병학회[DOI]
- 이병완, "Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017", The Korean Journal of Internal Medicine, 32(6), pp.967~973 (2017), 대한내과학회[DOI]
- 이병완, "Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017", Diabetes and Metabolism Journal, 41(5), pp.367~373 (2017), 대한당뇨병학회[DOI]
- 문민경, "Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus", Diabetes and Metabolism Journal, 41(5), pp.357~366 (2017), 대한당뇨병학회[DOI]
- 문민경, "Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus", The Korean Journal of Internal Medicine, 32(6), pp.974~983 (2017), 대한내과학회[DOI]
- 이상열, "Monotherapy in patients with type 2 diabetes mellitus", The Korean Journal of Internal Medicine, 32(6), pp.959~966 (2017), 대한내과학회[DOI]
- 이상열, "Monotherapy in Patients with Type 2 Diabetes Mellitus", Diabetes and Metabolism Journal, 41(5), pp.349~356 (2017), 대한당뇨병학회[DOI]
- American Diabetes Association, "Standards of medical care in diabetes: 2019 abridged for primary care providers", Clin Diabetes, 37, pp.11~34 (2019)
- American Diabetes Association, "6. Glycemic targets: standards of medical care in diabetes-2019", Diabetes Care, 42(Suppl 1), pp.S61~S70 (2019)
- American Diabetes Association, "9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2019", Diabetes Care, 42(Suppl 1), pp.S90~S102 (2019)
- American Diabetes Association, "12. Older adults: standards of medical care in diabetes-2019", Diabetes Care, 42(Suppl 1), pp.S139~S147 (2019)
- "Summary of revisions: standards of medical care in diabetes-2019", Diabetes Care, 42(Suppl 1), pp.S4~6S (2019)
- Neumiller JJ, "2018 Standards of care update : pharmacologic approaches to glycemic management in people with type 2 diabetes", Diabetes Spectr, 31, pp.254~260 (2018)
- Garber AJ, "Consensus statement by the American Association of Clinical Endocrinologists and American College Of Endocrinology on the comprehensive type 2 diabetes management algorithm : 2018 executive summary", Endocr Pract, 24, pp.91~120 (2018)
- McGuire H, "Management of type 2 diabetes in adults: summary of updated NICE guidance", BMJ, 353, pp.i1575~ (2016)
- Ceriello A, "International Diabetes Federation guideline for management of postmeal glucose : a review of recommendations", Diabet Med, 25, pp.1151~1156 (2008)
- Dunning T, "New IDF guideline for managing type 2 diabetes in older people", Diabetes Res Clin Pract, 103, pp.538~540 (2014)
- Action to Control Cardiovascular Risk in Diabetes Study Group, "Effects of intensive glucose lowering in type 2 diabetes", N Engl J Med, 358, pp.2545~2559 (2008)
- ADVANCE Collaborative Group, "Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes", N Engl J Med, 358, pp.2560~2572 (2008)
- Duckworth W, "Glucose control and vascular complications in veterans with type 2 diabetes", N Engl J Med, 360, pp.129~139 (2009)
- Araki E, "New glycemic targets for patients with diabetes from the Japan Diabetes Society", J Diabetes Investig, 8, pp.123~125 (2017)
- Haneda M, "Japanese Clinical Practice Guideline for Diabetes 2016", Diabetol Int, 9, pp.1~45 (2018)
- Namba M, "The current status of treatment-related severe hypoglycemia in Japanese patients with diabetes mellitus : a report from the committee on a survey of severe hypoglycemia in the Japan Diabetes Society", Diabetol Int, 9, pp.84~99 (2018)
- Mitchell BD, "Hypoglycaemic events in patients with type 2 diabetes in the United Kingdom : associations with patient-reported outcomes and self-reported HbA1c", BMC Endocr Disord, 13, pp.59~ (2013)
- Unger J, "Hypoglycemia in insulin-treated diabetes : a case for increased vigilance", Postgrad Med, 123, pp.81~91 (2011)
- Saleh TY, "Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM", Diabetes Care, 20, pp.1231~1236 (1997)
- McCall AL, "Insulin therapy and hypoglycemia", Endocrinol Metab Clin North Am, 41, pp.57~87 (2012)
- Sami Lee, "Korean Alcohol Guidelines for Moderate Drinking Based on Facial Flushing", Korean Journal of Family Medicine, 40(4), pp.204~211 (2019), 대한가정의학회[DOI]
- Committee of Clinical Practice Guideline, "Korean Diabetes Association. Treatment guideline for diabetes", J Korean Diabetes, 12(Suppl 1), pp.52~56 (2011)
- Cho DH, "Blood sugar control in alcohol-consuming diabetics", J Korean Diabetes, 13, pp.91~94 (2012)
- Qaseem A, "Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus : a guidance statement update from the American College of Physicians", Ann Intern Med, 168, pp.569~576 (2018)
- Hulkower RD, "Understanding hypoglycemia in hospitalized patients", Diabetes Manag (Lond), 4, pp.165~176 (2014)
- AGS Choosing Wisely Workgroup, "American Geriatrics Society identifies five things that healthcare providers and patients should question", J Am Geriatr Soc, 61, pp.622~631 (2013)
- Sussman JB, "Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older patients with diabetes mellitus", JAMA Intern Med, 175, pp.1942~1949 (2015)
- Yon Su Kim, "Frequency and Severity of Hypoglycemia in Type 2 Diabetes Mellitus Patients Treated with a Sulfonylurea-Based Regimen at University-Affiliated Hospitals in Korea: The Naturalistic Evaluation of Hypoglycemic Events in Diabetic Subjects Study", Korean Journal of Family Medicine, 40(4), pp.212~219 (2019), 대한가정의학회[DOI]
- Keith Tsz-Kit Chan, "Diabetes Care of Non-obese Korean Americans: Considerable Room for Improvement", Korean Journal of Family Medicine, 40(2), pp.72~79 (2019), 대한가정의학회[DOI]